,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,8.79062970657524e-07,0.000722589761880484
2,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0001663122615072,0.0461866692902115
3,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.000168564486460626,0.0461866692902115
4,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.00114233622294618,0.200792149975928
5,WP_BENZENE_METABOLISM,3,Up,0.00134626850771559,0.200792149975928
6,WP_COMPLEMENT_ACTIVATION,12,Up,0.00146563613121116,0.200792149975928
7,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.00269062327233901,0.291082922126257
8,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.00283292381631394,0.291082922126257
9,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.00634152065255773,0.554369283789627
10,WP_FERROPTOSIS,49,Up,0.00729824980475149,0.554369283789627
11,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.00811044851043926,0.554369283789627
12,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0081753893254727,0.554369283789627
13,WP_CHOLESTASIS,8,Up,0.00876739743219604,0.554369283789627
14,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.00980292743791727,0.575571882426286
15,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0121039883033071,0.637384876570836
16,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.0128700586226711,0.637384876570836
17,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.013181925671173,0.637384876570836
18,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0140700258710034,0.63751588239094
19,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.0155652404253302,0.63751588239094
20,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.0156223534962727,0.63751588239094
21,WP_FOXA2_PATHWAY,9,Up,0.016286902104878,0.63751588239094
22,WP_IRON_METABOLISM_DISORDERS,10,Up,0.017404739069903,0.640142785843399
23,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.0179115378034041,0.640142785843399
24,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.0197477856738004,0.650575662219106
25,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,53,Down,0.02049426957385,0.650575662219106
26,WP_COMPLEMENT_SYSTEM,50,Up,0.0210931526661017,0.650575662219106
27,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0220388243114732,0.650575662219106
28,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.0224544081521204,0.650575662219106
29,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.0234913720566784,0.650575662219106
30,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0247580354956459,0.650575662219106
31,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.0247580354956459,0.650575662219106
32,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.0263131662986056,0.650575662219106
33,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.0280432319737608,0.650575662219106
34,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.0284882891302997,0.650575662219106
35,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Down,0.0286546538376937,0.650575662219106
36,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.0295021463945065,0.650575662219106
37,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.0297336843130074,0.650575662219106
38,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.0300752739225377,0.650575662219106
39,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.0331404261637203,0.685224049505618
40,WP_AUTOPHAGY,27,Down,0.0352162012309389,0.685224049505618
41,WP_COPPER_HOMEOSTASIS,40,Up,0.037189269552665,0.685224049505618
42,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Up,0.0387392099740595,0.685224049505618
43,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.0394132219790685,0.685224049505618
44,WP_SPHINGOLIPID_PATHWAY,20,Down,0.0400540642674978,0.685224049505618
45,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.0409534052362271,0.685224049505618
46,WP_OSTEOPONTIN_SIGNALING,11,Down,0.0416200473058325,0.685224049505618
47,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.0425474334541068,0.685224049505618
48,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.0428814762643409,0.685224049505618
49,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.0430296903698475,0.685224049505618
50,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.0435134775417048,0.685224049505618
51,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Down,0.0437596135160051,0.685224049505618
52,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.0441709156595856,0.685224049505618
53,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.0442472409674306,0.685224049505618
54,WP_PYRIMIDINE_METABOLISM,71,Down,0.0457875786554693,0.685224049505618
55,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.0458483244803029,0.685224049505618
56,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.048127991226345,0.686051064619131
57,WP_CCL18_SIGNALING,20,Up,0.0482128899624467,0.686051064619131
58,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.0484074960436856,0.686051064619131
59,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0512161388433571,0.701747239532425
60,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.0512224262432427,0.701747239532425
61,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Up,0.0527427624075528,0.710730339328007
62,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.0538342688761111,0.713738209938118
63,WP_HUNGER_AND_SATIETY,2,Up,0.0552199287174182,0.720488593741551
64,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.056463293185561,0.725200421852049
65,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.0599498701034345,0.74619491913211
66,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.0605382179877807,0.74619491913211
67,WP_OSTEOBLAST_SIGNALING,3,Down,0.0621350570674009,0.74619491913211
68,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.0641570499316814,0.74619491913211
69,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Up,0.0642804484915247,0.74619491913211
70,WP_KALLMANN_SYNDROME,10,Up,0.0664599702957618,0.74619491913211
71,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0665868976186873,0.74619491913211
72,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0680625267385562,0.74619491913211
73,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.0687611907552904,0.74619491913211
74,WP_MEVALONATE_PATHWAY,7,Up,0.0693471407442754,0.74619491913211
75,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,19,Up,0.0707672359247255,0.74619491913211
76,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.0711951471724215,0.74619491913211
77,WP_IL1_SIGNALING,52,Down,0.0714882456665071,0.74619491913211
78,WP_PURINE_METABOLISM,10,Down,0.0722265851151813,0.74619491913211
79,WP_TAR_SYNDROME,43,Down,0.0722839607917154,0.74619491913211
80,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.0726223765578696,0.74619491913211
81,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.074979836248434,0.760906486372997
82,WP_SPINA_BIFIDA,10,Down,0.0763540119664075,0.764894253590539
83,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.0778746309448911,0.764894253590539
84,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.0781643762793252,0.764894253590539
85,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.0809987206540781,0.776247200241408
86,WP_OREXIN_RECEPTOR_PATHWAY,114,Down,0.0813496649431042,0.776247200241408
87,WP_SMALL_LIGAND_GPCRS,7,Up,0.0821984398055386,0.776247200241408
88,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.083101890050175,0.776247200241408
89,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.0847746708297042,0.782975049685583
90,WP_KININKALLIKREIN_PATHWAY,2,Up,0.0859112795413795,0.7846563531446
91,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.0873314166028226,0.786360525677937
92,WP_OSTEOCLAST_SIGNALING,9,Down,0.0880111537255112,0.786360525677937
93,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.093498823863978,0.798254013610325
94,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.0935473092665391,0.798254013610325
95,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.0940398256883184,0.798254013610325
96,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.0941957864214089,0.798254013610325
97,WP_PURINERGIC_SIGNALING,14,Up,0.0941978580537731,0.798254013610325
98,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.0976129601582674,0.798831571999531
99,WP_ECTODERM_DIFFERENTIATION,75,Up,0.0980921630020003,0.798831571999531
100,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Up,0.100242304228727,0.798831571999531
101,WP_BENZOAPYRENE_METABOLISM,5,Up,0.101156833499175,0.798831571999531
102,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Up,0.104243532926337,0.798831571999531
103,WP_PPARALPHA_PATHWAY,15,Up,0.105879555594826,0.798831571999531
104,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.107271655828621,0.798831571999531
105,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.107613250976151,0.798831571999531
106,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.108076739524238,0.798831571999531
107,WP_MRNA_PROCESSING,124,Down,0.110251847284108,0.798831571999531
108,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Up,0.11090941746274,0.798831571999531
109,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Up,0.11090941746274,0.798831571999531
110,WP_G_PROTEIN_SIGNALING,59,Up,0.111830312916758,0.798831571999531
111,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.111957419101254,0.798831571999531
112,WP_ALSTROM_SYNDROME,27,Down,0.112040035111011,0.798831571999531
113,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.112603666811529,0.798831571999531
114,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.112701537477458,0.798831571999531
115,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.113100878072919,0.798831571999531
116,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.115359745842077,0.798831571999531
117,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.115994122156498,0.798831571999531
118,WP_NRF2ARE_REGULATION,20,Up,0.11630806654812,0.798831571999531
119,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.118237390290477,0.798831571999531
120,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.124152347459803,0.798831571999531
121,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.124854152399067,0.798831571999531
122,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.126160271272772,0.798831571999531
123,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.126756591289917,0.798831571999531
124,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.127401221956413,0.798831571999531
125,WP_TRYPTOPHAN_METABOLISM,17,Up,0.12826491844638,0.798831571999531
126,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.128770492710775,0.798831571999531
127,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.128827663708932,0.798831571999531
128,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.129153571327486,0.798831571999531
129,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.129739621474436,0.798831571999531
130,WP_PROLACTIN_SIGNALING,69,Down,0.131184459808347,0.798831571999531
131,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.131502635108982,0.798831571999531
132,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,3,Up,0.132359123099602,0.798831571999531
133,WP_GPR40_PATHWAY,8,Down,0.133190874560163,0.798831571999531
134,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.133197768839576,0.798831571999531
135,WP_B_CELL_RECEPTOR_SIGNALING,83,Down,0.134803929078278,0.798831571999531
136,WP_CREATINE_PATHWAY,1,Down,0.13540412063977,0.798831571999531
137,WP_ONECARBON_METABOLISM,22,Down,0.135843047898814,0.798831571999531
138,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,18,Up,0.136071334418401,0.798831571999531
139,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.13805157638209,0.798831571999531
140,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Up,0.139457512836794,0.798831571999531
141,WP_STEROID_BIOSYNTHESIS,2,Down,0.140894241315165,0.798831571999531
142,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.141120986415124,0.798831571999531
143,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.141796872269262,0.798831571999531
144,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.142765096309603,0.798831571999531
145,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.143535542811214,0.798831571999531
146,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.143734533301843,0.798831571999531
147,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.14378775329434,0.798831571999531
148,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.143828555542495,0.798831571999531
149,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Down,0.145976120487699,0.805317926448914
150,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.148768545122455,0.80693396225829
151,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.149963841602894,0.80693396225829
152,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.150008344959284,0.80693396225829
153,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.150195737500631,0.80693396225829
154,WP_ZINC_HOMEOSTASIS,23,Up,0.156502253812043,0.833594351763455
155,WP_ATR_SIGNALING,10,Down,0.157186282875104,0.833594351763455
156,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.158951122772785,0.835833070594809
157,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.159642082826502,0.835833070594809
158,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.164135899470409,0.853922211168836
159,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.167308822217888,0.856960397573891
160,WP_MELATONIN_METABOLISM_AND_EFFECTS,18,Up,0.1693710188766,0.856960397573891
161,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.169716044150049,0.856960397573891
162,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.169810283841851,0.856960397573891
163,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.171137031223411,0.856960397573891
164,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,12,Down,0.172240273080223,0.856960397573891
165,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.173446740749104,0.856960397573891
166,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.174693114765332,0.856960397573891
167,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,87,Up,0.175922170970976,0.856960397573891
168,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.176182778536375,0.856960397573891
169,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.177018128034676,0.856960397573891
170,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.178924915678818,0.856960397573891
171,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.179195455074202,0.856960397573891
172,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.180186791384304,0.856960397573891
173,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.180357845231488,0.856960397573891
174,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.181482175610136,0.857346829606503
175,WP_IDO_METABOLIC_PATHWAY,6,Down,0.187940971541495,0.870638351988478
176,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.188479566486057,0.870638351988478
177,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Down,0.188919560534596,0.870638351988478
178,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.189862070653646,0.870638351988478
179,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.189925475392309,0.870638351988478
180,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.190661127112668,0.870638351988478
181,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.191709904756587,0.870638351988478
182,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.194577448041718,0.874054072193302
183,WP_SERINE_METABOLISM,5,Down,0.196584481114767,0.874054072193302
184,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.196892240975142,0.874054072193302
185,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Down,0.199690834782244,0.874054072193302
186,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.199776212914157,0.874054072193302
187,WP_DNA_MISMATCH_REPAIR,21,Down,0.201785463345902,0.874054072193302
188,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.203469764204379,0.874054072193302
189,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.203569878374842,0.874054072193302
190,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.20411557456463,0.874054072193302
191,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.20445564316865,0.874054072193302
192,WP_MONOAMINE_GPCRS,3,Up,0.205848589491215,0.874054072193302
193,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.206737790802562,0.874054072193302
194,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.208759480796102,0.874054072193302
195,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.209094067086339,0.874054072193302
196,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.209986569573279,0.874054072193302
197,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.211225726982634,0.874054072193302
198,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,79,Down,0.212317834507346,0.874054072193302
199,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.213205249076574,0.874054072193302
200,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.214665433330203,0.874054072193302
201,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.214853840544885,0.874054072193302
202,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,44,Down,0.215085830538469,0.874054072193302
203,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.215855202743601,0.874054072193302
204,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,41,Up,0.223103960500211,0.889222947951497
205,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.223181653330379,0.889222947951497
206,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.223506675101912,0.889222947951497
207,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.223928406600925,0.889222947951497
208,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.225400908697292,0.890767052640258
209,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.229867505811734,0.902544471617152
210,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.231437994493228,0.902544471617152
211,WP_NAD_METABOLISM,12,Down,0.232550277016739,0.902544471617152
212,WP_PROTEASOME_DEGRADATION,57,Down,0.235011194378748,0.902544471617152
213,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.235043819415897,0.902544471617152
214,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.23523047205689,0.902544471617152
215,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.23606698466872,0.902544471617152
216,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.238388235176859,0.90719967275638
217,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.240216260185591,0.909943621532514
218,WP_NEUROINFLAMMATION,10,Down,0.246445244913229,0.92578934232787
219,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.250078312612122,0.92578934232787
220,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.250675825013649,0.92578934232787
221,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.253012161871473,0.92578934232787
222,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.253033969703203,0.92578934232787
223,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.254162806183272,0.92578934232787
224,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.255902671052394,0.92578934232787
225,WP_PPAR_SIGNALING,36,Up,0.257036872699588,0.92578934232787
226,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.257865372218434,0.92578934232787
227,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.258288428987703,0.92578934232787
228,WP_METHYLATION_PATHWAYS,5,Up,0.260122286881406,0.92578934232787
229,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,10,Down,0.261126240172989,0.92578934232787
230,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.262413959395071,0.92578934232787
231,WP_NEPHROGENESIS,4,Down,0.263920916257171,0.92578934232787
232,WP_IRINOTECAN_PATHWAY,5,Up,0.266119829293366,0.92578934232787
233,WP_DOPAMINE_METABOLISM,7,Up,0.266156258450979,0.92578934232787
234,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.26632794353996,0.92578934232787
235,WP_INSULIN_SIGNALING,125,Down,0.266822422348271,0.92578934232787
236,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.268321681710723,0.92578934232787
237,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.268653738308481,0.92578934232787
238,WP_APOPTOSIS,71,Down,0.268965926581307,0.92578934232787
239,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.271808645236851,0.92578934232787
240,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.271854308943586,0.92578934232787
241,WP_ONCOSTATIN_M_SIGNALING,52,Down,0.272060594183897,0.92578934232787
242,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.273811201757762,0.92578934232787
243,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.27464946231051,0.92578934232787
244,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.275840768016134,0.92578934232787
245,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.275934779647601,0.92578934232787
246,WP_GLUCURONIDATION,7,Up,0.277121135378661,0.925990135289673
247,WP_WNT_SIGNALING_WP363,36,Up,0.278530676132562,0.926932047696218
248,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.282880612512286,0.933489351446055
249,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.283907710788413,0.933489351446055
250,WP_TROP2_REGULATORY_SIGNALING,41,Up,0.283907953602815,0.933489351446055
251,WP_MONOAMINE_TRANSPORT,11,Down,0.286925771691317,0.938902520119194
252,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.287838728795665,0.938902520119194
253,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.28908937772094,0.93925481615262
254,WP_SYNAPTIC_VESICLE_PATHWAY,21,Down,0.292287830803159,0.945907861890539
255,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.293782414479063,0.946706553385599
256,WP_FOLATE_METABOLISM,36,Down,0.294838050689432,0.946706553385599
257,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.298046092373149,0.95112142403692
258,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.299685807075755,0.95112142403692
259,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.301261177679595,0.95112142403692
260,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.301790920647769,0.95112142403692
261,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.30736935443706,0.95112142403692
262,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.307689005875911,0.95112142403692
263,WP_CAMKK2_PATHWAY,29,Up,0.308507816985134,0.95112142403692
264,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.309509156499842,0.95112142403692
265,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.309981998911908,0.95112142403692
266,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.31091907521522,0.95112142403692
267,WP_MACROPHAGE_MARKERS,8,Down,0.311322257394576,0.95112142403692
268,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Down,0.311549147340867,0.95112142403692
269,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.312922986774698,0.95112142403692
270,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.315286811810964,0.95112142403692
271,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.318091093516165,0.95112142403692
272,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.318747508378912,0.95112142403692
273,WP_BLADDER_CANCER,28,Down,0.319145033156935,0.95112142403692
274,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.320149106252215,0.95112142403692
275,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.321219912121269,0.95112142403692
276,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.322110651834446,0.95112142403692
277,WP_ATM_SIGNALING,33,Down,0.322302500497494,0.95112142403692
278,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.325075323584828,0.95112142403692
279,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.326331324838562,0.95112142403692
280,WP_TAMOXIFEN_METABOLISM,2,Up,0.326394548842203,0.95112142403692
281,WP_LEPTIN_SIGNALING,69,Down,0.326397498892816,0.95112142403692
282,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.328095861822458,0.95112142403692
283,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.328388211280959,0.95112142403692
284,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,19,Up,0.329547474694346,0.95112142403692
285,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.329768376947107,0.95112142403692
286,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.332068501229707,0.954406671366501
287,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,14,Up,0.335682021960397,0.957350978124054
288,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.336350125237608,0.957350978124054
289,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.338182721722904,0.957350978124054
290,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.339062834544625,0.957350978124054
291,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.341181876283682,0.957350978124054
292,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.343148063762585,0.957350978124054
293,WP_PEPTIDE_GPCRS,11,Up,0.343537249328507,0.957350978124054
294,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,60,Down,0.343846403543901,0.957350978124054
295,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.346975060594893,0.957350978124054
296,WP_ERBB_SIGNALING,66,Down,0.349146287035789,0.957350978124054
297,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.350251955658064,0.957350978124054
298,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.350285691530715,0.957350978124054
299,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,37,Up,0.350727875117612,0.957350978124054
300,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Up,0.351459415120593,0.957350978124054
301,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.351574152667382,0.957350978124054
302,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.351727488313217,0.957350978124054
303,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,84,Down,0.353183791159671,0.958142166116335
304,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.356553305223301,0.960588343706616
305,WP_JOUBERT_SYNDROME,70,Up,0.357669099374894,0.960588343706616
306,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.359464454850364,0.960588343706616
307,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Up,0.361522814974574,0.960588343706616
308,WP_VEGFAVEGFR2_SIGNALING,331,Up,0.364344953577746,0.960588343706616
309,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.36456367638369,0.960588343706616
310,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.365667915306041,0.960588343706616
311,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,62,Up,0.365699898955151,0.960588343706616
312,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.366784606875178,0.960588343706616
313,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.367508096605891,0.960588343706616
314,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.367879792566954,0.960588343706616
315,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.369025055718971,0.960588343706616
316,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.370562638177652,0.960588343706616
317,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.37106644780719,0.960588343706616
318,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.372915151152427,0.960588343706616
319,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.373925625774154,0.960588343706616
320,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,18,Down,0.373951666649777,0.960588343706616
321,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.377532017530157,0.966491311471834
322,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Up,0.379619004488635,0.966491311471834
323,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.381955357530914,0.966491311471834
324,WP_GPCRS_OTHER,11,Down,0.382698919514509,0.966491311471834
325,WP_DRAVET_SYNDROME,11,Down,0.384023955946071,0.966491311471834
326,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.385437309050756,0.966491311471834
327,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.385451341978407,0.966491311471834
328,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Up,0.385655900441316,0.966491311471834
329,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.389427814183466,0.9729776998748
330,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.393399935097899,0.974825702595146
331,WP_ENDODERM_DIFFERENTIATION,80,Up,0.393495409454451,0.974825702595146
332,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Up,0.393725222945971,0.974825702595146
333,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.39596872461576,0.977436311213678
334,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.401848739247565,0.987675486412566
335,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.403130268793899,0.987675486412566
336,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.404010388259851,0.987675486412566
337,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.404922918395419,0.987675486412566
338,WP_ANGIOGENESIS,13,Down,0.406386375793917,0.988312428705916
339,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,16,Up,0.410230525618003,0.992832567525267
340,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.413662893695266,0.992832567525267
341,WP_IL4_SIGNALING,50,Down,0.419399305236968,0.992832567525267
342,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.420452971402155,0.992832567525267
343,WP_NOTCH_SIGNALING_WP268,34,Up,0.421485771777186,0.992832567525267
344,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.423786827193174,0.992832567525267
345,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.423786827193174,0.992832567525267
346,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.427442135429827,0.992832567525267
347,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.429225911633992,0.992832567525267
348,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.430038187433713,0.992832567525267
349,WP_IL7_SIGNALING,23,Down,0.430564539764492,0.992832567525267
350,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.430758879190903,0.992832567525267
351,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Up,0.433453700158988,0.992832567525267
352,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Down,0.434347193541426,0.992832567525267
353,WP_GASTRIN_SIGNALING,91,Down,0.435394815822444,0.992832567525267
354,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.436438434215892,0.992832567525267
355,WP_ANDROGEN_RECEPTOR_SIGNALING,76,Up,0.436563505742699,0.992832567525267
356,WP_KIT_RECEPTOR_SIGNALING,49,Down,0.436581472086946,0.992832567525267
357,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.436881744350693,0.992832567525267
358,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.437425093917817,0.992832567525267
359,WP_CHOLESTEROL_METABOLISM,48,Up,0.439082142420434,0.992832567525267
360,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.440550094607308,0.992832567525267
361,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.442861893900446,0.992832567525267
362,WP_OMEGA9_FATTY_ACID_SYNTHESIS,9,Up,0.444435658408578,0.992832567525267
363,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.447307420980588,0.992832567525267
364,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.449074001209501,0.992832567525267
365,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.45044789948408,0.992832567525267
366,WP_ENDOTHELIN_PATHWAYS,10,Up,0.45262410698837,0.992832567525267
367,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,14,Up,0.453645213081921,0.992832567525267
368,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.455613540407585,0.992832567525267
369,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,86,Up,0.455844758344565,0.992832567525267
370,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.455986985160635,0.992832567525267
371,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.456369835560494,0.992832567525267
372,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.456837287897418,0.992832567525267
373,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.457104833414327,0.992832567525267
374,WP_VITAMIN_B12_DISORDERS,9,Up,0.459171431201856,0.992832567525267
375,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.459994894092386,0.992832567525267
376,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.461836357409321,0.992832567525267
377,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,38,Down,0.463306493849028,0.992832567525267
378,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.46394908617754,0.992832567525267
379,WP_NEOVASCULARIZATION_PROCESSES,21,Down,0.469615726279429,0.992832567525267
380,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.473568052108881,0.992832567525267
381,WP_GPCRS_CLASS_A_RHODOPSINLIKE,38,Up,0.473936910986213,0.992832567525267
382,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.475391516359628,0.992832567525267
383,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.475884489105933,0.992832567525267
384,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.478577293678232,0.992832567525267
385,WP_TRANSLATION_FACTORS,49,Down,0.480140327085936,0.992832567525267
386,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,167,Down,0.480490900339101,0.992832567525267
387,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.482412277329747,0.992832567525267
388,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.482883044262985,0.992832567525267
389,WP_SILDENAFIL_TREATMENT,11,Down,0.483043059299897,0.992832567525267
390,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,52,Down,0.483484055117773,0.992832567525267
391,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.483671692839772,0.992832567525267
392,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Down,0.484423883242972,0.992832567525267
393,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.485033117194275,0.992832567525267
394,WP_RAC1PAK1P38MMP2_PATHWAY,50,Up,0.4913244345886,0.992832567525267
395,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.493299009939418,0.992832567525267
396,WP_ARYLAMINE_METABOLISM,1,Up,0.493325609440578,0.992832567525267
397,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.493361380381256,0.992832567525267
398,WP_RANKLRANK_SIGNALING,47,Down,0.495952067972007,0.992832567525267
399,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.497490765293835,0.992832567525267
400,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.5001698180796,0.992832567525267
401,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,47,Up,0.500614074082885,0.992832567525267
402,WP_EICOSANOID_SYNTHESIS,13,Up,0.501931703515219,0.992832567525267
403,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.50406950321845,0.992832567525267
404,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Up,0.505396055561362,0.992832567525267
405,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.507077194720121,0.992832567525267
406,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.507108876917515,0.992832567525267
407,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Down,0.509120469964647,0.992832567525267
408,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.510251576486138,0.992832567525267
409,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.511574246697673,0.992832567525267
410,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.512636171401357,0.992832567525267
411,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.514170996273133,0.992832567525267
412,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.515157883185619,0.992832567525267
413,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.519200075761206,0.992832567525267
414,WP_IL19_SIGNALING,20,Up,0.519978085222786,0.992832567525267
415,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Up,0.520458556870542,0.992832567525267
416,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.521344211517778,0.992832567525267
417,WP_SPINAL_CORD_INJURY,63,Down,0.521915135525522,0.992832567525267
418,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.522553967586016,0.992832567525267
419,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,25,Up,0.523582129920256,0.992832567525267
420,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.523705727572497,0.992832567525267
421,WP_GASTRIC_CANCER_NETWORK_2,24,Down,0.524077403485657,0.992832567525267
422,WP_GLUTATHIONE_METABOLISM,10,Up,0.524343342928864,0.992832567525267
423,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Up,0.524518364786264,0.992832567525267
424,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.526380663239977,0.992832567525267
425,WP_GASTRIC_CANCER_NETWORK_1,15,Down,0.528771278616523,0.992832567525267
426,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.531243068862287,0.992832567525267
427,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.536484018584083,0.992832567525267
428,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.539760080395752,0.992832567525267
429,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.541455327536418,0.992832567525267
430,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.542193018604429,0.992832567525267
431,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Up,0.54354649365935,0.992832567525267
432,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.544274790303223,0.992832567525267
433,WP_IL5_SIGNALING,37,Up,0.545282051855517,0.992832567525267
434,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.545711926558815,0.992832567525267
435,WP_CILIARY_LANDSCAPE,182,Down,0.548547275332665,0.992832567525267
436,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,64,Down,0.548633277339852,0.992832567525267
437,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.551048951551776,0.992832567525267
438,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.552637605028185,0.992832567525267
439,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.552736014028121,0.992832567525267
440,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,31,Up,0.553611945157445,0.992832567525267
441,WP_HYPERTROPHY_MODEL,13,Down,0.554041554533198,0.992832567525267
442,WP_MATRIX_METALLOPROTEINASES,7,Up,0.554206070794091,0.992832567525267
443,WP_ALLOGRAFT_REJECTION,50,Up,0.554518358275427,0.992832567525267
444,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.555915911818865,0.992832567525267
445,WP_CILIOPATHIES,120,Up,0.55673294264811,0.992832567525267
446,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.557040967578313,0.992832567525267
447,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.558396188896849,0.992832567525267
448,WP_SEROTONIN_AND_ANXIETY,5,Down,0.56189864746644,0.992832567525267
449,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.564582098454437,0.992832567525267
450,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.56475264405691,0.992832567525267
451,WP_AMINO_ACID_METABOLISM,57,Up,0.565175450985238,0.992832567525267
452,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,64,Up,0.565284041638741,0.992832567525267
453,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.565522880013999,0.992832567525267
454,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.565522880013999,0.992832567525267
455,WP_WNT_SIGNALING_AND_PLURIPOTENCY,56,Up,0.565573221841148,0.992832567525267
456,WP_NPHP1_DELETION_SYNDROME,10,Up,0.5683254728278,0.992832567525267
457,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.572027853243402,0.992832567525267
458,WP_ENERGY_METABOLISM,41,Down,0.572784002332651,0.992832567525267
459,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.578259670648498,0.992832567525267
460,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.579027717934774,0.992832567525267
461,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.58225664064677,0.992832567525267
462,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Down,0.583947186626595,0.992832567525267
463,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.584033298283984,0.992832567525267
464,WP_CYTOSINE_METHYLATION,7,Down,0.585225953472663,0.992832567525267
465,WP_NEURAL_CREST_DIFFERENTIATION,35,Up,0.585341289561466,0.992832567525267
466,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Down,0.587181509204537,0.992832567525267
467,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.587628873840473,0.992832567525267
468,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.590679780537773,0.992832567525267
469,WP_HIPPOYAP_SIGNALING,16,Down,0.595070341802976,0.992832567525267
470,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.595737799798582,0.992832567525267
471,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.595905141209417,0.992832567525267
472,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.596009816223139,0.992832567525267
473,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.597971491408572,0.992832567525267
474,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.599530355646388,0.992832567525267
475,WP_RETT_SYNDROME,29,Down,0.601128824363633,0.992832567525267
476,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.60307063294389,0.992832567525267
477,WP_HISTONE_MODIFICATIONS,35,Up,0.604164761425318,0.992832567525267
478,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.604358855690628,0.992832567525267
479,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.606322650119648,0.992832567525267
480,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,16,Down,0.608376998762033,0.992832567525267
481,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.608841809468339,0.992832567525267
482,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.609557763752349,0.992832567525267
483,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Down,0.611431917941803,0.992832567525267
484,WP_DNA_DAMAGE_RESPONSE,57,Down,0.612178415694366,0.992832567525267
485,WP_VITAMIN_B12_METABOLISM,23,Up,0.613365082064011,0.992832567525267
486,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,3,Down,0.613668781380951,0.992832567525267
487,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.61409928153321,0.992832567525267
488,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.617789045667979,0.992832567525267
489,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,80,Down,0.618581668180504,0.992832567525267
490,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.620332770549336,0.992832567525267
491,WP_INTEGRATED_CANCER_PATHWAY,39,Up,0.620795291581888,0.992832567525267
492,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.622709785053536,0.992832567525267
493,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.622817538345597,0.992832567525267
494,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.623389214469964,0.992832567525267
495,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.625165174234674,0.992832567525267
496,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.626136252963714,0.992832567525267
497,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.626619588681266,0.992832567525267
498,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.626814827630434,0.992832567525267
499,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.628163949638582,0.992832567525267
500,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.628910197978913,0.992832567525267
501,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.629291500006336,0.992832567525267
502,WP_CELL_CYCLE,92,Up,0.63177617006736,0.992832567525267
503,WP_RETINOL_METABOLISM,6,Up,0.631838929376367,0.992832567525267
504,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,13,Up,0.637494701699787,0.992832567525267
505,WP_AXON_GUIDANCE,35,Up,0.637693410237373,0.992832567525267
506,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.638080782799237,0.992832567525267
507,WP_WNT_SIGNALING_WP428,57,Up,0.638516951397552,0.992832567525267
508,WP_PRION_DISEASE_PATHWAY,27,Up,0.639943454740221,0.992832567525267
509,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.643315472491163,0.992832567525267
510,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,55,Down,0.646005718421396,0.992832567525267
511,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.64639543369022,0.992832567525267
512,WP_IL17_SIGNALING,25,Down,0.647373619423419,0.992832567525267
513,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.649585274810558,0.992832567525267
514,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.651053505153161,0.992832567525267
515,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.651340650375015,0.992832567525267
516,WP_PDGFRBETA_PATHWAY,26,Up,0.651360021763284,0.992832567525267
517,WP_NRF2_PATHWAY,68,Up,0.651575878903548,0.992832567525267
518,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.651737976119922,0.992832567525267
519,WP_CANCER_PATHWAYS,292,Up,0.656089509821941,0.992832567525267
520,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,3,Up,0.656253882355722,0.992832567525267
521,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.65684235934398,0.992832567525267
522,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.657438928767998,0.992832567525267
523,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.658233859141348,0.992832567525267
524,WP_NRXN1_DELETION_SYNDROME,2,Up,0.659679010315425,0.992832567525267
525,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.661472360755582,0.992832567525267
526,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.661570871630821,0.992832567525267
527,WP_EGFEGFR_SIGNALING,135,Down,0.662184854421167,0.992832567525267
528,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.664480766962198,0.992832567525267
529,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.666247659764341,0.992832567525267
530,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.666386140098149,0.992832567525267
531,WP_PDGF_PATHWAY,36,Down,0.667336484892442,0.992832567525267
532,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.668146418359102,0.992832567525267
533,WP_PREIMPLANTATION_EMBRYO,21,Up,0.668256307439278,0.992832567525267
534,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.669681556563734,0.992832567525267
535,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,9,Up,0.669705832628222,0.992832567525267
536,WP_OVARIAN_INFERTILITY,21,Down,0.672159166841551,0.992832567525267
537,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.674154827908186,0.992832567525267
538,WP_HEME_BIOSYNTHESIS,8,Down,0.674154827908186,0.992832567525267
539,WP_TNFALPHA_SIGNALING,83,Up,0.674558949561281,0.992832567525267
540,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.675440048246286,0.992832567525267
541,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.675905015780705,0.992832567525267
542,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.675997248730516,0.992832567525267
543,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.677562987994365,0.992832567525267
544,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.677584229883029,0.992832567525267
545,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.678449485863389,0.992832567525267
546,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.679698319174848,0.992832567525267
547,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.680863638720514,0.992832567525267
548,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.681052604084875,0.992832567525267
549,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.681052604084875,0.992832567525267
550,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.681135025762075,0.992832567525267
551,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.682189546598022,0.992832567525267
552,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.683893383603656,0.992832567525267
553,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.687575863710311,0.992832567525267
554,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Up,0.688100398319678,0.992832567525267
555,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.688507188947275,0.992832567525267
556,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.689819825798938,0.992832567525267
557,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.691355505970293,0.992832567525267
558,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.693057207517047,0.992832567525267
559,WP_GLIOBLASTOMA_SIGNALING,64,Down,0.695177979192014,0.992832567525267
560,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.696614843681492,0.992832567525267
561,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.697680670336604,0.992832567525267
562,WP_VITAMIN_D_METABOLISM,5,Down,0.698034192009073,0.992832567525267
563,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Up,0.698249977658503,0.992832567525267
564,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.700928618254473,0.992832567525267
565,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.701347462198936,0.992832567525267
566,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.70256350635462,0.992832567525267
567,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.705937463189449,0.992832567525267
568,WP_IL9_SIGNALING,15,Down,0.710423040545825,0.992832567525267
569,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.711140467085905,0.992832567525267
570,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.711167469284726,0.992832567525267
571,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Up,0.712181156864515,0.992832567525267
572,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.712659197656158,0.992832567525267
573,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.71331000604798,0.992832567525267
574,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.713419760388231,0.992832567525267
575,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,8,Down,0.713622320797315,0.992832567525267
576,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.714897735506646,0.992832567525267
577,WP_ACUTE_MYELOID_LEUKEMIA,54,Up,0.715245795857055,0.992832567525267
578,WP_TGFB_SMAD_SIGNALING,7,Up,0.71534350881051,0.992832567525267
579,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.720247367122161,0.992832567525267
580,WP_PI3KAKT_SIGNALING,172,Down,0.720784075698507,0.992832567525267
581,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,59,Down,0.72207731910258,0.992832567525267
582,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.722735169151962,0.992832567525267
583,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.723195014880376,0.992832567525267
584,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.72320089571539,0.992832567525267
585,WP_MIRNA_BIOGENESIS,6,Down,0.723252033908813,0.992832567525267
586,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.724326426986466,0.992832567525267
587,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.725928134472184,0.992832567525267
588,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.729117353010975,0.992832567525267
589,WP_ASPIRIN_AND_MIRNAS,8,Up,0.729788591517051,0.992832567525267
590,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.732968436624647,0.992832567525267
591,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.733917305639632,0.992832567525267
592,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.736726326624479,0.992832567525267
593,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.737897521721348,0.992832567525267
594,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Down,0.739201532308531,0.992832567525267
595,WP_HIPPO_SIGNALING_REGULATION,42,Up,0.739275613241327,0.992832567525267
596,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.739956974201576,0.992832567525267
597,WP_RAS_SIGNALING,113,Up,0.740739691416561,0.992832567525267
598,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.742992927799614,0.992832567525267
599,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.743007084772174,0.992832567525267
600,WP_IL11_SIGNALING,40,Down,0.74498008430626,0.992832567525267
601,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.747986605572724,0.992832567525267
602,WP_BURN_WOUND_HEALING,57,Up,0.749739882114451,0.992832567525267
603,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.753555339821258,0.992832567525267
604,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Down,0.753747192496421,0.992832567525267
605,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.755608372765265,0.992832567525267
606,WP_P38_MAPK_SIGNALING,31,Down,0.758305138120582,0.992832567525267
607,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.762427942403344,0.992832567525267
608,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.762974594866223,0.992832567525267
609,WP_LUNG_FIBROSIS,31,Down,0.763064195442384,0.992832567525267
610,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.764234273983782,0.992832567525267
611,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.76524535530141,0.992832567525267
612,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.766581626487165,0.992832567525267
613,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Down,0.767603248565574,0.992832567525267
614,WP_HEPATITIS_B_INFECTION,115,Down,0.768948285999381,0.992832567525267
615,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.770345609668038,0.992832567525267
616,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.771762747403663,0.992832567525267
617,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.77190303846208,0.992832567525267
618,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.772436380356675,0.992832567525267
619,WP_IL6_SIGNALING,39,Up,0.773143618923122,0.992832567525267
620,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.773860870949971,0.992832567525267
621,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.773947594190424,0.992832567525267
622,WP_MESODERMAL_COMMITMENT_PATHWAY,72,Down,0.775062849574301,0.992832567525267
623,WP_KLEEFSTRA_SYNDROME,25,Down,0.775380241383016,0.992832567525267
624,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.77569256591557,0.992832567525267
625,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.776010349617585,0.992832567525267
626,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.776287573677987,0.992832567525267
627,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Up,0.777126671402716,0.992832567525267
628,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.778379425662598,0.992832567525267
629,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.779927683809033,0.992832567525267
630,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Up,0.782828049505161,0.992832567525267
631,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.78318996497348,0.992832567525267
632,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.786271209336359,0.992832567525267
633,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.79015623394613,0.992832567525267
634,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.790489556940223,0.992832567525267
635,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.791482552599216,0.992832567525267
636,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.793100086487291,0.992832567525267
637,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.794207488753957,0.992832567525267
638,WP_MTHFR_DEFICIENCY,18,Down,0.794345616681947,0.992832567525267
639,WP_CELLULAR_PROTEOSTASIS,6,Up,0.795382422691635,0.992832567525267
640,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.795560615826102,0.992832567525267
641,WP_IL2_SIGNALING,37,Down,0.796093848384683,0.992832567525267
642,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.796833463680629,0.992832567525267
643,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.797136576407966,0.992832567525267
644,WP_VALPROIC_ACID_PATHWAY,8,Up,0.799422658095195,0.992832567525267
645,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.800184833200065,0.992832567525267
646,WP_GLYOXYLATE_METABOLISM,5,Down,0.800222829764467,0.992832567525267
647,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.80061000010091,0.992832567525267
648,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.800689236870859,0.992832567525267
649,WP_NETRINUNC5B_SIGNALING,35,Down,0.802200884600722,0.992832567525267
650,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,32,Down,0.802564562984592,0.992832567525267
651,WP_INTEGRINMEDIATED_CELL_ADHESION,69,Up,0.803724388448578,0.992832567525267
652,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,266,Up,0.804413224057402,0.992832567525267
653,WP_CHEMOKINE_SIGNALING,106,Up,0.807428215940213,0.992832567525267
654,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.809139637044403,0.992832567525267
655,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.809371679130724,0.992832567525267
656,WP_KREBS_CYCLE_DISORDERS,11,Down,0.810548312594552,0.992832567525267
657,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.810939085479063,0.992832567525267
658,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.813225692198523,0.992832567525267
659,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.813272784663242,0.992832567525267
660,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.816436142120463,0.992832567525267
661,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.817110856231995,0.992832567525267
662,WP_TP53_NETWORK,16,Down,0.817887931854817,0.992832567525267
663,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.819033309860633,0.992832567525267
664,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.8194309276661,0.992832567525267
665,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.820077339475807,0.992832567525267
666,WP_MALE_INFERTILITY,65,Down,0.820215415626099,0.992832567525267
667,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.823156756518168,0.992832567525267
668,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,87,Down,0.823938104290337,0.992832567525267
669,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.824354688393259,0.992832567525267
670,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.824869929729327,0.992832567525267
671,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.825844655842232,0.992832567525267
672,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Up,0.82721464605322,0.992832567525267
673,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.829619458436063,0.992832567525267
674,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.832338654638989,0.992832567525267
675,WP_ID_SIGNALING,11,Up,0.832559107173567,0.992832567525267
676,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.833184565058005,0.992832567525267
677,WP_G13_SIGNALING,29,Up,0.833213360806437,0.992832567525267
678,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.833680835929084,0.992832567525267
679,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.834054327806422,0.992832567525267
680,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.834920056354831,0.992832567525267
681,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Down,0.835193722982626,0.992832567525267
682,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Down,0.835503367993643,0.992832567525267
683,WP_NEPHROTIC_SYNDROME,28,Up,0.836217738209627,0.992832567525267
684,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,6,Down,0.836293894312762,0.992832567525267
685,WP_ENDOMETRIAL_CANCER,48,Down,0.837654577378228,0.992832567525267
686,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.838276919857333,0.992832567525267
687,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.841642425717775,0.992832567525267
688,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.842165961792736,0.992832567525267
689,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.842276084132146,0.992832567525267
690,WP_NUCLEAR_RECEPTORS_METAPATHWAY,173,Down,0.84399861781081,0.992832567525267
691,WP_FOCAL_ADHESION,115,Down,0.844228276170904,0.992832567525267
692,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.84898239702034,0.992832567525267
693,WP_CORI_CYCLE,11,Down,0.849352739102556,0.992832567525267
694,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.849704731169737,0.992832567525267
695,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.850753089852106,0.992832567525267
696,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,13,Up,0.850937054518568,0.992832567525267
697,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.851602342173148,0.992832567525267
698,WP_NOTCH_SIGNALING_WP61,47,Down,0.852931497199643,0.992832567525267
699,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.85308636669581,0.992832567525267
700,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.855113746346133,0.992832567525267
701,WP_THERMOGENESIS,72,Up,0.856763446107116,0.992832567525267
702,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.857567843835356,0.992832567525267
703,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.85812099094889,0.992832567525267
704,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.858331895662964,0.992832567525267
705,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.863120425843772,0.992832567525267
706,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.864715083182563,0.992832567525267
707,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.864899384088372,0.992832567525267
708,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.866138101610217,0.992832567525267
709,WP_FOXP3_IN_COVID19,9,Down,0.866871626125133,0.992832567525267
710,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.869825661176525,0.992832567525267
711,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.870119917025611,0.992832567525267
712,WP_TRANSSULFURATION_PATHWAY,8,Down,0.870344963106767,0.992832567525267
713,WP_AGERAGE_PATHWAY,53,Up,0.871114521543583,0.992832567525267
714,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.872690620751279,0.992832567525267
715,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Up,0.872960509902273,0.992832567525267
716,WP_BREAST_CANCER_PATHWAY,82,Up,0.873997119257748,0.992832567525267
717,WP_HEART_DEVELOPMENT,15,Down,0.875760383565541,0.992832567525267
718,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.876646681085132,0.992832567525267
719,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.877221917183354,0.992832567525267
720,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,52,Up,0.877669444563476,0.992832567525267
721,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,9,Down,0.878273327058127,0.992832567525267
722,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Up,0.880259058693359,0.992832567525267
723,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.880619399724023,0.992832567525267
724,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.880973612846657,0.992832567525267
725,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,85,Up,0.882026973779738,0.992832567525267
726,WP_FRAGILE_X_SYNDROME,83,Down,0.887823013034594,0.992832567525267
727,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.889849105547883,0.992832567525267
728,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Up,0.891148411621524,0.992832567525267
729,WP_MELANOMA,53,Down,0.89151417594122,0.992832567525267
730,WP_NUCLEAR_RECEPTORS,20,Down,0.892933727570485,0.992832567525267
731,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.896151303440479,0.992832567525267
732,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.897233877994156,0.992832567525267
733,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Down,0.898466685458938,0.992832567525267
734,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,27,Down,0.90003341264891,0.992832567525267
735,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.900092923702058,0.992832567525267
736,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.900326386148184,0.992832567525267
737,WP_IL18_SIGNALING,184,Up,0.900365571521229,0.992832567525267
738,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Down,0.900805262476329,0.992832567525267
739,WP_AEROBIC_GLYCOLYSIS,9,Up,0.901969979920559,0.992832567525267
740,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Up,0.901969979920559,0.992832567525267
741,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.902690905960684,0.992832567525267
742,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,62,Up,0.903596642364296,0.992832567525267
743,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Up,0.904288227655633,0.992832567525267
744,WP_UREA_CYCLE_AND_RELATED_DISEASES,2,Down,0.904789923263802,0.992832567525267
745,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.906488471564917,0.992832567525267
746,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,3,Down,0.907336138833498,0.992832567525267
747,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.907556155364615,0.992832567525267
748,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.90776323569362,0.992832567525267
749,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.908027764171511,0.992832567525267
750,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,72,Down,0.909668283830585,0.992832567525267
751,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.91051329523545,0.992832567525267
752,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.910721475466519,0.992832567525267
753,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,73,Down,0.91179476446526,0.992832567525267
754,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.913276620904962,0.992832567525267
755,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.913459847725897,0.992832567525267
756,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.916374838572499,0.992832567525267
757,WP_BASE_EXCISION_REPAIR,29,Up,0.919589047440982,0.992832567525267
758,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.921262260131616,0.992832567525267
759,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.923505405978386,0.992832567525267
760,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.925518565960023,0.992832567525267
761,WP_IL3_SIGNALING,46,Up,0.92571760956899,0.992832567525267
762,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.926306090169632,0.992832567525267
763,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.928115815218368,0.992832567525267
764,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Down,0.928249791187313,0.992832567525267
765,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.929938149411495,0.992832567525267
766,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.930991399777377,0.992832567525267
767,WP_ESTROGEN_SIGNALING,21,Up,0.93152684382426,0.992832567525267
768,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,4,Up,0.931755837630735,0.992832567525267
769,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.932355723301711,0.992832567525267
770,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Up,0.932430431335063,0.992832567525267
771,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Up,0.933640522616348,0.992832567525267
772,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Up,0.936773660135629,0.992832567525267
773,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,2,Down,0.937699829355963,0.992832567525267
774,WP_PLEURAL_MESOTHELIOMA,242,Down,0.938026270862041,0.992832567525267
775,WP_ADIPOGENESIS,82,Up,0.938271219975904,0.992832567525267
776,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.941529464729919,0.992832567525267
777,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Down,0.943198802851995,0.992832567525267
778,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.943861430574076,0.992832567525267
779,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.944637463613641,0.992832567525267
780,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.94512208336955,0.992832567525267
781,WP_BARDETBIEDL_SYNDROME,64,Up,0.945667627410173,0.992832567525267
782,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.946144708267973,0.992832567525267
783,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.946756872543685,0.992832567525267
784,WP_ALZHEIMERS_DISEASE,181,Up,0.94814302373155,0.992832567525267
785,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,181,Up,0.94814302373155,0.992832567525267
786,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.949458199674967,0.992944834774584
787,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.952608852223518,0.993978209745383
788,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Down,0.9540889929333,0.993978209745383
789,WP_MAPK_CASCADE,30,Up,0.95489528566963,0.993978209745383
790,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.958531953010189,0.993978209745383
791,WP_METABOLIC_EPILEPTIC_DISORDERS,54,Down,0.95919558254571,0.993978209745383
792,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.95976188001503,0.993978209745383
793,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.960763305064598,0.993978209745383
794,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.961049384715828,0.993978209745383
795,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.961329290447177,0.993978209745383
796,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.963673809713459,0.994608895432131
797,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,58,Up,0.96511731384436,0.994608895432131
798,WP_BDNFTRKB_SIGNALING,26,Down,0.966230533396469,0.994608895432131
799,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Up,0.966779206143884,0.994608895432131
800,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.969400122462737,0.994868678954716
801,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.969452325842735,0.994868678954716
802,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.97103892169794,0.995254356154248
803,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Up,0.975460663713244,0.995730119147634
804,WP_IL26_SIGNALING,31,Up,0.975880102571359,0.995730119147634
805,WP_MEASLES_VIRUS_INFECTION,100,Up,0.976200158273207,0.995730119147634
806,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.976348510989043,0.995730119147634
807,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.980620675597929,0.997229260196919
808,WP_DNA_REPLICATION,34,Down,0.981196151537809,0.997229260196919
809,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.983363732779505,0.997229260196919
810,WP_NUCLEOTIDE_GPCRS,6,Down,0.983767301643494,0.997229260196919
811,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.983884343089661,0.997229260196919
812,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.991018409045459,0.998637285074529
813,WP_MAPK_SIGNALING,160,Up,0.991686379920885,0.998637285074529
814,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.991858232367105,0.998637285074529
815,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.99369689461261,0.998637285074529
816,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.994373584626747,0.998637285074529
817,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.994702028252548,0.998637285074529
818,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.996766964322516,0.998637285074529
819,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.996783669449331,0.998637285074529
820,WP_SLEEP_REGULATION,10,Up,0.996796196970674,0.998637285074529
821,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.997422397866409,0.998637285074529
822,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Down,0.99954878995483,0.99954878995483
